The diagnostic performance of quantitative mapping in breast cancer patients: a preliminary study using synthetic MRI
Open Access
- 14 December 2020
- journal article
- research article
- Published by Springer Science and Business Media LLC in Cancer Imaging
- Vol. 20 (1), 1-9
- https://doi.org/10.1186/s40644-020-00365-4
Abstract
Previous studies have indicated that quantitative MRI (qMR) is beneficial for diagnosis of breast cancer. As a novel qMR technology, synthetic MRI (syMRI) may be advantageous by offering simultaneous generation of T1 and T2 mapping in one scan within a few minutes and without concern to the deposition of the gadolinium contrast agent in cell nucleus. In this study, the potential of quantitative mapping derived from Synthetic MRI (SyMRI) to diagnose breast cancer was investigated. From April 2018 to May 2019, a total of 87 patients with suspicious breast lesions underwent both conventional and SyMRI before treatment. The quantitative metrics derived from SyMRI, including T1 and T2 values, were measured in breast lesions. The diagnostic performance of SyMRI was evaluated with unpaired Student’s t-tests, receiver operating characteristic curve analysis and multivariate logistic regression analysis. The AUCs of quantitative values were compared using Delong test. Among 77 patients who met the inclusion criteria, 48 were diagnosed with histopathological confirmed breast cancers, and the rest had benign lesions. The breast cancers showed significantly higher T1 (1611.61 ± 215.88 ms) values and lower T2 (80.93 ± 7.51 ms) values than benign lesions. The area under the ROC curve (AUC) values were 0.931 (95% CI: 0.874–0.989) and 0.883 (95% CI: 0.810–0.956) for T1 and T2 maps, respectively, in diagnostic discrimination between breast cancers and benign lesions. A slightly increased AUC of 0.978 (95% CI: 0.915–0.993) was achieved by combining those two relaxation-based quantitative metrics. In conclusion, our preliminary study showed that the quantitative T1 and T2 values obtained by SyMRI could distinguish effectively between benign and malignant breast lesions, and T1 relaxation time showed the highest diagnostic efficiency. Furthermore, combining the two quantitative relaxation metrics further improved their diagnostic performance.Keywords
Funding Information
- National Key Research and Development Program of China (2017YFC0112605)
- Medical Science Research Foundation of Guangdong Province of China (20180005)
This publication has 32 references indexed in Scilit:
- T1 MappingMagnetic Resonance Imaging Clinics of North America, 2015
- Parameters of Dynamic Contrast-Enhanced MRI as Imaging Markers for Angiogenesis and Proliferation in Human Breast CancerMedical Science Monitor, 2015
- Assessing liver function in patients with HBV-related HCC: a comparison of T1 mapping on Gd-EOB-DTPA-enhanced MR imaging with DWIEuropean Radiology, 2014
- Effect of vascular haemoglobin concentrations on ultrasound-guided diffuse optical tomography in differentiating benign from malignant breast lesionsEuropean Radiology, 2014
- BI-RADS UpdateRadiologic Clinics of North America, 2014
- Exposure to parabens at the concentration of maximal proliferative response increases migratory and invasive activity of human breast cancer cells in vitroJournal of Applied Toxicology, 2014
- Preoperative Breast MRI Can Reduce the Rate of Tumor-Positive Resection Margins and Reoperations in Patients Undergoing Breast-Conserving SurgeryAmerican Journal of Roentgenology, 2013
- Quantified Tumor T1 Is a Generic Early-Response Imaging Biomarker for Chemotherapy Reflecting Cell ViabilityClinical Cancer Research, 2010
- Lesion T2 relaxation times and volumes predict the response of malignant breast lesions to neoadjuvant chemotherapyMagnetic Resonance Imaging, 2008
- Detection of Breast Malignancy: Diagnostic MR Protocol for Improved SpecificityRadiology, 2004